Bristol-Myers Squibb
BMY
#171
Rank
NZ$228.95 B
Marketcap
NZ$112.01
Share price
1.06%
Change (1 day)
33.76%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2023 (TTM): NZ$6.42

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$8.06. In 2022 the company made an earnings per share (EPS) of NZ$5.32 a decrease over its 2021 EPS that were of NZ$5.66.

EPS history for Bristol-Myers Squibb from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$6.4220.76%
2022NZ$5.32-6.04%
2021NZ$5.66-179.29%
2020NZ-$7.13-281.37%
2019NZ$3.93-27.21%
2018NZ$5.40388.71%
2017NZ$1.11-76.78%
2016NZ$4.76175.26%
2015NZ$1.73-19.83%
2014NZ$2.16-22.44%
2013NZ$2.7834.48%
2012NZ$2.07-47.03%
2011NZ$3.9121.67%
2010NZ$3.21-66.36%
2009NZ$9.54104.2%
2008NZ$4.67140.37%
2007NZ$1.9436.25%
2006NZ$1.43-47.37%
2005NZ$2.7123.58%
2004NZ$2.19-23.6%
2003NZ$2.8750.47%
2002NZ$1.911.9%
2001NZ$1.87-43.85%
2000NZ$3.341.08%
1999NZ$3.3036.03%
1998NZ$2.43-15.53%
1997NZ$2.8713.38%
1996NZ$2.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.91 47.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.36 16.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.27-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.44 29.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.10 583.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.00 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.53-56.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$4.21-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.77-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.70 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK